Mike Essl

423 total citations
10 papers, 253 citations indexed

About

Mike Essl is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Mike Essl has authored 10 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Mike Essl's work include CAR-T cell therapy research (5 papers), Protease and Inhibitor Mechanisms (3 papers) and Mesenchymal stem cell research (2 papers). Mike Essl is often cited by papers focused on CAR-T cell therapy research (5 papers), Protease and Inhibitor Mechanisms (3 papers) and Mesenchymal stem cell research (2 papers). Mike Essl collaborates with scholars based in Germany, United States and Switzerland. Mike Essl's co-authors include Gerd Klein, Volker Huppert, Wilhelm K. Aicher, Johannes T. Wessels, Michael Sixt, Dieter P. Reinhardt, Takako Sasaki, Heinz Schwarz, Claudia Müller and Erhard Seifried and has published in prestigious journals such as Blood, Journal of Cell Science and Annals of the Rheumatic Diseases.

In The Last Decade

Mike Essl

9 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mike Essl Germany 8 133 90 83 44 39 10 253
Cuicui Lyu China 11 244 1.8× 159 1.8× 94 1.1× 71 1.6× 50 1.3× 36 443
Ankit Mahendra India 9 129 1.0× 97 1.1× 122 1.5× 67 1.5× 63 1.6× 12 326
Hitomi Hosoya United States 9 90 0.7× 69 0.8× 36 0.4× 45 1.0× 32 0.8× 24 238
Katharina Mattenheimer Germany 8 90 0.7× 74 0.8× 140 1.7× 53 1.2× 12 0.3× 10 271
Forhad Ahmed United Kingdom 6 157 1.2× 113 1.3× 196 2.4× 59 1.3× 27 0.7× 9 380
Karoline Lipnik Austria 8 83 0.6× 122 1.4× 85 1.0× 17 0.4× 14 0.4× 13 280
Miriam Ritz Germany 7 89 0.7× 70 0.8× 142 1.7× 61 1.4× 11 0.3× 10 255
Jingzhu Zhang United States 7 88 0.7× 114 1.3× 91 1.1× 65 1.5× 9 0.2× 9 279
Jianjian Jin United States 9 217 1.6× 117 1.3× 132 1.6× 42 1.0× 39 1.0× 25 363
Chee Jia Chin United States 7 157 1.2× 215 2.4× 93 1.1× 94 2.1× 39 1.0× 7 430

Countries citing papers authored by Mike Essl

Since Specialization
Citations

This map shows the geographic impact of Mike Essl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Essl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Essl more than expected).

Fields of papers citing papers by Mike Essl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Essl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Essl. The network helps show where Mike Essl may publish in the future.

Co-authorship network of co-authors of Mike Essl

This figure shows the co-authorship network connecting the top 25 collaborators of Mike Essl. A scholar is included among the top collaborators of Mike Essl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike Essl. Mike Essl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Aleksandrova, Krasimira, Christoph Priesner, Anette Melk, et al.. (2019). Functionality and Cell Senescence of CD4/ CD8-Selected CD20 CAR T Cells Manufactured Using the Automated CliniMACS Prodigy® Platform. Transfusion Medicine and Hemotherapy. 46(1). 47–54. 42 indexed citations
2.
Pershin, Dmitry, Elena Kurnikova, А. М. Попов, et al.. (2018). Title Point-of-Care Production of CD19 CAR-T Cells in an Automated Closed-System: Report of First Clinical Experience. Blood. 132(Supplement 1). 5202–5202.
4.
Spohn, Gabriele, Eliza Wiercinska, Darja Karpova, et al.. (2015). Automated CD34+ cell isolation of peripheral blood stem cell apheresis product. Cytotherapy. 17(10). 1465–1471. 36 indexed citations
5.
Essl, Mike, et al.. (2013). Fully Automated Clinical-Scale Separation of CD133+ Cells From Bone Marrow Aspirate. Biology of Blood and Marrow Transplantation. 19(2). S349–S349. 1 indexed citations
6.
Granzin, Markus, Mike Essl, Sabine Müller, et al.. (2013). Integrated Clinical Scale Manufacturing System for Cellular Products Derived by Magnetic Cell Separation, Centrifugation and Cell Culture. Chemie Ingenieur Technik. 85(1-2). 103–110. 45 indexed citations
7.
Essl, Mike, Stefan Stevanović, Oliver Pötz, et al.. (2012). Release of Matrix Metalloproteinase-8 During Physiological Trafficking and Induced Mobilization of Human Hematopoietic Stem Cells. Stem Cells and Development. 22(9). 1307–1318. 21 indexed citations
8.
Hoberg, M., Maximilian Rudert, Shanli Tsui, et al.. (2009). Transforming growth factor β1 and laminin-111 cooperate in the induction of interleukin-16 expression in synovial fibroblasts from patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 69(1). 270–275. 15 indexed citations
9.
Hergeth, Sonja, et al.. (2008). Characterization and functional analysis of osteoblast-derived fibulins in the human hematopoietic stem cell niche. Experimental Hematology. 36(8). 1022–1034. 25 indexed citations
10.
Wessels, Johannes T., Claudia Müller, Mike Essl, et al.. (2006). Characterization of a conduit system containing laminin-5 in the human thymus: a potential transport system for small molecules. Journal of Cell Science. 119(7). 1396–1405. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026